| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Infighting Labor VS Corporate Executives, Who Started It? |
|
Digg It - Infighting Labor VS Corporate Executives, Who Started It?
It seems like whenever we open the financial news we see the unions suing a company or going on strike, claiming the company is According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product cheating them, over working them, unsafe work place, not enough benefits, low pay or messing with their pensions. Then they sa ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in y that the company executives get paid too much. The company then says that the employees do work slow down, want money the com lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. pany needs to operate, expand or pay in dividends to keep shareholders from dumping the stock. There is so much infighting in here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe the largest US corporations that it is amazing they are productive at all, in fact many are not, with more bureaucracy and inef d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro iciencies than the United States Government. Often the employees feel cheated on their promise for their pension, benefits and ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc potential for upward mobility and pay raises. We all agree and realize that some of these issues are reality based and exist. A easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi nd should realize that the modern employee also is somewhat to blame for lack of work ethic and switching jobs every 2.3 years nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically on average while demanding the world. And okay, yes, I agree that we have Infighting between Labor and Corporate Executives, bu and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ t I ask the question; who started it? I do not know who started it, but a company which fully trains someone, that person up an ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi leaves saying thanks a lot and see you later is problematic to say the least. Look how many companies are on your resume, if y ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ou have one you see? Not good or bad, it maybe fewer than most actually and in that case good for you, you are a team player. R dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ead this: http://www.parthe.net/_cwg1003/0000006b.htm http://www.parthe.net/_cwg1003/00000074.htm http://www.parthe.net/_cwg cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin 1003/00000072.htm http://parthe.net/_cwg1001/000000a0.htm Now many will say that; “A company can make the salaried and hourly tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen employees dance like puppets and walk around in fear that they’ll be laid off.” And indeed this maybe true, yet what option d t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel es the company have when they are being attacked from every angle; by The Unions, The Government Regulators, Lawyers and Lawsui ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ts? And while we are discussing those wonderful workers out there who provide so much for these companies let us realize that m y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products any are so busy trying to have a work place mishap so they can sue the company it is not funny. Boy have I have got some storie . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de s, no wonder the company executives say; “kill all the lawyers (TWICE!) Revive them so you can kill them again.” Many a busines elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip s man will say that the lawyers; they are the real International Terrorists. We ought to call them "Lawhadists." Think about it tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Business Brokerage Services: Get a Good Deal Did You Come to Think of Advertising Inflatables?
|